CVS Health Corp (CVS) Position Increased by FDx Advisors Inc.

FDx Advisors Inc. increased its holdings in CVS Health Corp (NYSE:CVS) by 5.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,925 shares of the pharmacy operator’s stock after purchasing an additional 3,589 shares during the quarter. FDx Advisors Inc.’s holdings in CVS Health were worth $5,686,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Horan Capital Advisors LLC. grew its stake in shares of CVS Health by 3.2% in the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after purchasing an additional 1,000 shares during the last quarter. Community Bank N.A. grew its stake in shares of CVS Health by 7.3% in the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after purchasing an additional 1,362 shares during the last quarter. FIL Ltd grew its stake in shares of CVS Health by 13.8% in the second quarter. FIL Ltd now owns 514,836 shares of the pharmacy operator’s stock worth $41,424,000 after purchasing an additional 62,318 shares during the last quarter. Midwest Investment Management LLC grew its stake in shares of CVS Health by 6.2% in the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after purchasing an additional 1,245 shares during the last quarter. Finally, ETRADE Capital Management LLC grew its stake in shares of CVS Health by 3.7% in the second quarter. ETRADE Capital Management LLC now owns 55,653 shares of the pharmacy operator’s stock worth $4,478,000 after purchasing an additional 1,979 shares during the last quarter. 81.62% of the stock is currently owned by institutional investors.

In other news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the transaction, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.61% of the stock is currently owned by company insiders.

CVS has been the topic of several recent analyst reports. Oppenheimer reissued a “buy” rating and issued a $95.00 target price on shares of CVS Health in a research note on Monday, October 9th. SunTrust Banks set a $85.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a report on Thursday, October 12th. Mizuho set a $90.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a report on Tuesday, October 24th. Cowen set a $86.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a report on Sunday, October 29th. Finally, Needham & Company LLC upgraded shares of CVS Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $69.02 to $79.00 in a report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $86.66.

CVS Health Corp (CVS) opened at $78.78 on Friday. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.72. The stock has a market cap of $79,800.00, a P/E ratio of 16.28, a PEG ratio of 1.25 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last released its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same period last year, the business earned $1.64 earnings per share. The business’s revenue was up 3.5% on a year-over-year basis. sell-side analysts predict that CVS Health Corp will post 5.89 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.54%. CVS Health’s payout ratio is 41.32%.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corp (CVS) Position Increased by FDx Advisors Inc.” was originally reported by Markets Daily and is the property of of Markets Daily. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.themarketsdaily.com/2018/01/14/cvs-health-corp-cvs-position-increased-by-fdx-advisors-inc.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply